CPTP 3.3 Neuropharmacology 1 (Antidepressants) Flashcards
What creates biological vulnerabilities for depression and mood disorders?
- Genetic predisposition
* Early adverse life experiences
Are catecholamines monoamines?
Yes
list the catecholamines
- NA
- Serotonin
- Dopamine
Outline briefly the monoamine hypothesis?
Depression is due to a deficit in central monoamine neurotransmission.
What evidence is there against monoamine theory?
- Cocaine inhibits NA uptake, but isn’s an antidepressant
* Lowered monoamines aren’t seen in patients with depression
Outline the biochemical pathway for the synthesis of 5-HT
Tryptophan –TPH–> 5-HTP
5-HTP –AADC–> 5-HT
TPH = tyrptophan hydroxylase AADC = 5-hydroxytryptophan decarboxylase
What occurs to 5-HT after synthesis?
Either stored into vesicles or broken down by MAO into 5-HIAA and extruded
What are the most important postsynaptic 5-HT receptors?
- 5-HT 1A
- 5-HT 1B
- 5-HT 2A
- 5-HT 2C
What is the 5-HT autoreceptor?
5-HT 1A
How is serotonin terminated?
SERT in the presynaptic membrane pumps 5-HT back into the presynaptic neurone.
It can then either be transported back into vesicles or broken down by MAO
What two pharmacological targets are there for antidepressants?
The termination step:
• MAO
• SERT
Which antidepressants block 5-HT reuptake?
- Tricyclic antidepressants
- SSRIs
- SNRIs (serotonin & noradrenaline)
Which antidepressants block NA reuptake?
- SNRIs (serotonin & noradrenaline)
* NARIs
What effect do reuptake inhibitors have?
They prolong the effects of the neurotransmitter
What are the clinical limitations of TCAs?
- Delayed onset of 2 weeks before effective
- M1 antagonistic effects
- H1 antagonistic effects
- a1-adrenoreceptor antagonistic effects
- Cardiotoxic in overdose
What do TCA M1 antagonistic side effects include?
- dry mouth
- blurred vision
- constipation
- urinary retention